-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Segments
-
Pharmaceutical
-
Consumer Health
-
MedTech
-
Public Health & Government
-
Payer & Provider
Pharmaceutical (Global page)
Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn More
Consumer Health
Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MORE
MedTech
Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn more
Public Health & Government
Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MORE
Payer & Provider
Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreHealthcare Provider Solutions
Solutions
-
Research & Development
-
Real World Evidence
-
Information Insights
-
Market Research
-
Strategy Consulting
-
Contract Sales & Medical Solutions
-
Patient Solutions
-
AI, Digital & Technology Solutions
Research & Development (Global page)
Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn More
Real World Evidence
Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MORE
Information Insights
Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MORE
Market Research
Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORE
Strategy Consulting (Global page)
Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MORERelated Solutions
Contract Sales & Medical Solutions (Global page)
Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MORE
Patient Solutions (Global page)
A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MORE
AI, Digital & Technology Solutions
Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREOur Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Featured Event
"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreCareer Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search Jobs
Blog
Keeping up with SEA pharmacist digital engagement
Sep 21, 2020
Walking into a pharmacy, we typically see someone in a white coat standing behind a counter dispensing medication. But far from only dispensing prescription drugs, pharmacists add tremendous value to the community —often closing patient care gap. Pharmacists advise patients and consumers alike, from possible medication side effects to self-care and lifestyle advice.
The COVID-19 pandemic has created change in healthcare professional, consumer and pharmacist behaviour. Providing quality care required alternative solutions, some pharmacists adapting to online communication and purchase channels. Similarly, healthcare companies adapted, and should continue to do so, to engage and support pharmacists in the “new normal”.
Using our Southeast Asia WellTrack study (May – Aug 2020), we were able to gain insight into pharmacist preference across the region. As countries emerged from lockdown, overall the data showed 4 in 5 SEA Pharmacists preferred traditional detailing via phone call. However, in different SEA countries, pharmacist preference varied, and this would impact engagement approaches required to drive higher impact and impression post-quarantine:
- Singapore pharmacists are open to detailing via remote platforms, with a +10% interest in email detailing. However, 9 in 10 pharmacists continue to prefer detailing via phone calls
- Malaysia pharmacists continue to express a preference in ‘traditional’ digital channels, with an 80% preference for detailing via emails, SMS, phone calls. They expressed the lowest preference for chat platforms, unless used in the context of online round table discussions where 9 in 10 pharmacists expressed an interest
- Vietnam pharmacists expressed a low interest in digital detailing, except for detailing via remote platform which saw a +11% change
- Thailand pharmacists showed the highest willingness to move towards digital engagements in the region, particular for rep detailing via video platforms and pre-recorded webinars, at +16% and +13% respectively
- Philippines pharmacists are also open to newer digital approaches such as social network detailing, but not forgoing traditional digital such as emails where 3 in 5 still show an interest
- Indonesia pharmacists currently have the lowest adoption rate for digital detailing vs. other SEA countries. Their preferred modes of rep detailing are via SMS, chat platforms and emails
Across the region, pharmacists are responding to new digital detailing approaches at different paces. Any strategy should consider where to transition from traditional digital models to new digital options. Customized engagement is a reality across markets, and within the healthcare professional ecosystem. Compared to pharmacists, in most SEA countries, physicians expressed an equal preference for both traditional and digital types of interactions post-pandemic.
Keeping up with SEA pharmacist engagement preferences requires investment and willingness to understand the pharmacist adoption archetypes (early adopters, fast followers, late adopters) —and create the appropriate engagement strategy.
For more information, please feel free to contact us.